University of Bordeaux Reports Findings in Heart Attack (One-year care pathway after acute myocardial infarction in 2018: prescription, medical care and medication compliance, using an insurance reimbursement database French disease): Heart disorders and diseases – Heart attack

FEBRUARY 11, 2022 (NewsRx) — By a News Reporter – Staff News Editor at Daily Insurance News — New Research on Heart Disorders and Diseases – Heart Attack reports. According to news from Pessac, France, by NewsRx correspondents, the research said, “Myocardial infarction is a leading cause of morbidity and mortality. Recommendations have been published to optimize medical care and involve optimizing the care pathway and hospital-city coordination.

Our news reporters got a quote from the research of the University of Bordeaux, “To describe the care pathway for myocardial infarction during the year following hospital discharge, as well as the use and adherence to secondary prevention medications. A cohort study was carried out using data from the main French health insurance reimbursement database for the ex-Aquitaine region. Information on the medical and pharmaceutical care of hospitalized patients in 2018 was collected over 12 months. Adherence to treatment was assessed using the proportion of days covered by treatment and persistence. A total of 3015 patients were included, and the mean age was 66 years. Nearly 76% of patients were reimbursed for BAS (combined beta-blocker/antiplatelet/lipid-lowering prescription), BASI (combined beta-blocker/antiplatelet/hypolipidemic/angiotensin-converting enzyme prescription) or AS Treatment (combined antiplatelet/hypolipidemic prescription) . Therapeutic compliance was approximately 83% for aspirin and 75% for lipid-lowering drugs for persistence at 1 year. At the same time, the proportion of covered days was sub-optimal. Nearly 4% of patients died after discharge from hospital, 45% went to a cardiac rehabilitation center and 23% had at least one readmission to hospital for any reason. Patients had an average of 11 general practitioner consultations during the year. Nearly 41% of patients did not have a consultation with a cardiologist and 38.4% had at least two consultations. Rehabilitation and visits to the general practitioner were associated with compliance. These new results provide clear insights into the medical environment of patients and help us improve the transition of care.

According to the news editors, the research concluded, “Close collaboration between healthcare professionals is very important in the early stages of outpatient follow-up.”

This research has been peer reviewed.

For more information on this research, see: Care pathway one year after an acute myocardial infarction in 2018: prescription, medical care and medication compliance, from a database of insurance reimbursements sickness. Cardiovascular Disease Archives2022. Cardiovascular Disease Archives can be contacted at: Elsevier Masson, Corp Off, 65 Camille Desmoulins CS50083 Issy-Les-Moulineaux, 92442 Paris, France. (Elsevier –; Archives of Cardiovascular Diseases –


News correspondents report that further information can be obtained from Karin Martin LatryInserm UMR 1034, Biology of cardiovascular diseases, University of Bordeaux1, avenue de Magellan, 33600 Pessac, France. Other authors of this research include Philippe Latry, Veronique Moysan, Camille Berges, Pierre CosteHerve Douard, Yann Pucheu, Nadine Agosti and Thierry Couffinhal.

The direct object identifier (DOI) for this additional information is: This DOI is a link to a free or paid online electronic document, and can be your direct source for a journal article and its citation.

Journal editor contact details Cardiovascular Disease Archives is: Elsevier Masson, Corp Off, 65 Camille Desmoulins CS50083 Issy-Les-Moulineaux, 92442 Paris, France.

(Our reports provide factual information on research and discoveries from around the world.)

About Michael Bill

Check Also

Pfizer launches patient assistance app to improve affordability and access to medicines

Launch of IUdo app helps patients on support programs by providing greater accessibility to Pfizer …